United States Neurodegenerative Drugs Market was valued at USD 9.80 Billion in 2022 and is projected to reach USD 14.10 Billion by 2030, growing at a CAGR of 5.2% from 2024 to 2030.
The US Neurodegenerative Drugs Market has seen a significant surge in demand due to an increasing number of people being affected by conditions like Alzheimer's, Parkinson's, and Huntington's disease. With the growing aging population and rising awareness around these conditions, the need for effective neurodegenerative drugs is expected to rise sharply. The market is projected to expand rapidly as both pharmaceutical companies and healthcare industries seek new treatments and innovative solutions to combat neurodegenerative disorders.
Neurodegenerative disorders have become one of the biggest health challenges in the US, making the Neurodegenerative Drugs Market an essential sector. As of now, the demand for drugs is primarily driven by the rising prevalence of Alzheimer's and Parkinson's diseases. In fact, it is estimated that by 2050, nearly 12 million Americans will be living with Alzheimer's disease, making the requirement for effective treatment options increasingly crucial.
The US pharmaceutical and biotechnology industries play a key role in the advancement of these drugs. These industries are collaborating with research organizations, utilizing advanced technologies, and investing heavily in the development of new medications. For example, monoclonal antibodies and gene therapy are promising therapeutic options that have shown substantial progress in clinical trials. Additionally, the use of artificial intelligence (AI) in drug discovery is expected to shorten development timelines and create highly targeted drugs.
Key drivers of growth in the Neurodegenerative Drugs Market include an aging population, increasing healthcare expenditures, and the expansion of research funding. The market is categorized into several types of treatments, such as disease-modifying drugs, symptomatic treatments, and neuroprotective agents. Each of these categories targets different aspects of neurodegenerative diseases, whether slowing the disease’s progression, alleviating symptoms, or protecting brain cells from further damage.
Overall, the US Neurodegenerative Drugs Market continues to evolve with increasing investment in research and development, along with a high demand from industries aiming to address critical unmet needs in patient care. The collaboration between pharmaceutical companies, healthcare providers, and research institutions will play a pivotal role in shaping the future of this market.
Get an In-Depth Research Analysis of the US Neurodegenerative Drugs Market Size And Forecast [2025-2032]
Â
Novartis
Pfizer
Merck Serono
Biogen Idec
TEVA Pharmaceuticals
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Neurodegenerative Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Neurodegenerative Drugs Market
Cholinesterase Inhibitors
Glutamate Inhibitors
Monoamine Oxidase Inhibitors
Therapeutic Antibodies
Neuroprotective Agents
Alzheimer's Disease
Parkinson's Disease
Amyotrophic Lateral Sclerosis (ALS)
Huntington's Disease
Multiple Sclerosis
Oral
Injectable
Intranasal
Transdermal
Intravenous
Age Group
Gender
Receptor Modulators
Enzyme Inhibitors
Channel Blockers
Cytokine Inhibitors
Neurotransmitter Precursors
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Neurodegenerative Drugs Market Research Analysis
1. Introduction of the US Neurodegenerative Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Neurodegenerative Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Neurodegenerative Drugs Market, By Type
6. US Neurodegenerative Drugs Market, By Application
7. US Neurodegenerative Drugs Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Neurodegenerative Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/